Explore

Trendline Trendline
Citeline Reports First Decline in Pharma Pipeline Since 1990s, Impacting Drug Development

Citeline Reports First Decline in Pharma Pipeline Since 1990s, Impacting Drug Development

Citeline Reports First Decline in Pharma Pipeline Since 1990s, Impacting Drug Development
Trendline Trendline
Germany's Direct Compression Sugars Market Faces Complex Challenges and Opportunities

Germany's Direct Compression Sugars Market Faces Complex Challenges and Opportunities

Germany's Direct Compression Sugars Market Faces Complex Challenges and Opportunities
Trendline Trendline
FDA Reversals in Rare Disease Trials Highlight Challenges with External Controls

FDA Reversals in Rare Disease Trials Highlight Challenges with External Controls

FDA Reversals in Rare Disease Trials Highlight Challenges with External Controls
Trendline Trendline
API's Strategic Approach to Drug Development Aims to Overcome 'Valley of Death'

API's Strategic Approach to Drug Development Aims to Overcome 'Valley of Death'

API's Strategic Approach to Drug Development Aims to Overcome 'Valley of Death'
Trendline Trendline
Augmented Intelligence Revolutionizes Biopharma Innovation Amid Investment Challenges

Augmented Intelligence Revolutionizes Biopharma Innovation Amid Investment Challenges

Augmented Intelligence Revolutionizes Biopharma Innovation Amid Investment Challenges
Trendline Trendline
OneCyte and Kemp Proteins Partner to Enhance Cell Line Development with Machine Learning

OneCyte and Kemp Proteins Partner to Enhance Cell Line Development with Machine Learning

OneCyte and Kemp Proteins Partner to Enhance Cell Line Development with Machine Learning
Trendline Trendline
Trump Finalizes 100% Tariffs on Imported Medicines, Sparking Industry Concerns

Trump Finalizes 100% Tariffs on Imported Medicines, Sparking Industry Concerns

Trump Finalizes 100% Tariffs on Imported Medicines, Sparking Industry Concerns
Trendline Trendline
Biotech Companies Viking and Structure Targeted by Big Pharma Amid Metabolic Health Boom

Biotech Companies Viking and Structure Targeted by Big Pharma Amid Metabolic Health Boom

Biotech Companies Viking and Structure Targeted by Big Pharma Amid Metabolic Health Boom
Trendline Trendline
TriNetX and Regeneron Collaborate to Enhance Drug Discovery with Access to 300 Million Patient Health Records

TriNetX and Regeneron Collaborate to Enhance Drug Discovery with Access to 300 Million Patient Health Records

TriNetX and Regeneron Collaborate to Enhance Drug Discovery with Access to 300 Million Patient Health Records
Trendline Trendline
Viking and Structure Therapeutics Become Key Targets in Metabolic Health Sector

Viking and Structure Therapeutics Become Key Targets in Metabolic Health Sector

Viking and Structure Therapeutics Become Key Targets in Metabolic Health Sector
Trendline Trendline
Trump Administration Imposes 100% Tariffs on Imported Medicines, Affecting Smaller Pharmaceutical Companies

Trump Administration Imposes 100% Tariffs on Imported Medicines, Affecting Smaller Pharmaceutical Companies

Trump Administration Imposes 100% Tariffs on Imported Medicines, Affecting Smaller Pharmaceutical Companies
Trendline Trendline
Anthropic Acquires Biotech AI Startup Coefficient Bio for $400 Million, Expanding AI in Drug Discovery

Anthropic Acquires Biotech AI Startup Coefficient Bio for $400 Million, Expanding AI in Drug Discovery

Anthropic Acquires Biotech AI Startup Coefficient Bio for $400 Million, Expanding AI in Drug Discovery